Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
Merck & Co., Inc.
 
 
Company Website:
http://www.merck.com
Newsroom

 
Business Focus:
Pharmaceutical
Stock Ticker:
MRK
Company Description:
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.  Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs.  The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them.  Merck also publishes unbiased health information as a not-for-profit service. 
 
Company Ownership:
(NYSE: MRK)

Global Headquarters:
Merck & Co., Inc.
One Merck Drive
P.O. Box 100
Whitehouse Station, NJ 08889-0100 USA
telephone: 908-423-1000

Company Contacts:
Media Contact(s)
Kim Angelastro
[Media Contact]
 
David Caouette
[Head of Media Relations]
 
Kelley P. Dougherty
[Communications Director]
 
Claire Gillespie
[Associate Director, Corporate Media Relations]
 
Skip Irvine
[US Public Affairs (Merck/Schering-Plough)]
 
Alex Kelly
[Director of Communications]
 
Julie Lux
[Global Product Communications Director]
 
Patrick Witmer
[Director of Communications]
 
Rosemarie Yancosek
[ (Merck/Schering-Plough)]
 
Enid Johnson
[Media Relation Manager]
 
Amy Rose
[Media Relation Manager]
 
Investor Relations Contact(s)
Joseph Romanelli
[ (Merck/Schering-Plough)]
 

Company Officials:
Kenneth Frazier
[CEO and President]
 
Fred Hassan
[Former Chairman of the Board, Chief Executive Officer (Schering-Plough)]
 
Richard Clark
[Chairman of the Board]
 
Annemarie D'Esposito
[Executive Director, Managed Care (Merck/Schering-Plough)]
 
Robert McMahon
[President, U.S. Market, Global Human Health]
 
Mark Timney
[President of Global Human Health]
 
Charles Farthing MD
[Director for Scientific Affairs - US Human Health division]
 
David Abrahamson
[Executive Medical Director]
 
Alisa Arkenberg-Buccola
[Senior Regional Marketing Manager (Merck/Schering-Plough)]
 
Roderick Carter
[Executive Director - Strategic Customers]
 
Richard Wagner
[National Account Director]
 
Angela M. Stewart JD
[Director & Counsel, Public Policy and Government Affairs]
 
Matt Forney
[Account Executive]
 
Kevin Ashliman
 
Mary Baker
[National Account Executive]
 
Glenn A. Belemjian
[National Account Executive]
 
Daniel Coleman
[Account Executive]
 
Robert A. Dribbon
[Director - Health Care System Strategy]
 
Timothy C. Duffey
[Executive Director]
 
Kristin Edwards
[Senior Account Executive]
 
Bridgette Heller
[Executive Vice President and President, Merck Consumer Care]
 
Shane Jensen
[Sr. Executive Vaccine Specialist]
 
Michael Kaplan
[Former Vice President and Deputy Director]
 
Ronald Kierpa
[Sr Business Director, USHH Managed Care]
 
Sheldon Kong
[Executive Director]
 
Bruce N. Kuhlik
[Senior Vice President]
 
Jon Martin
[Managed Care Brand Marketing]
 
Dennis O'Brien MBA
[Sr. Director, Managed Care Marketing]
 
Grace Pelkowski
[Account Executive]
 
Matthew Stafford
[National Account Executive]
 
David Stevenson
[Investment Principal for Merck Ghif]
 
Mark Stewart
[Senior National Account Executive (Merck/Schering-Plough)]
 
Bill Taranto
[President - Merck Global Health Innovation Fund]
 
Suzanne Vlasic
[Senior Manager, Customer Marketing]
 
Peter Wack
[Senior Oncology Reimbursement Specialist]
 
View Additional Employees and Representatives
View Past Employees/Others with Past Affiliations

Company News/Coverage:
Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management
Merck: New Survey Showed That Most People Living With HIV Were More Concerned About Their Other Chronic Health Conditions Than Their HIV
Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery
Randy Jackson Partners with Merck to Urge People with Type 2 Diabetes to Take Their Diabetes to Heart
Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman
View all remaining Company News/Coverage headlines
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions